Canadian analysts eye ‘catalysts’ to reverse cannabis stock freefall
Canadian cannabis stocks are down over 40% since peaking in early January, leading analysts to speculate about what might ultimately trigger a rebound.
Cronos Group
German court hits brakes on medical cannabis cultivation plan
A German court slammed the brakes on the country’s plan to grant contracts to cultivate medical marijuana, giving international exporters an even bigger head start over domestic production as the country struggles to meet MMJ demand.
A representative for the Higher Regional Court of Dusseldorf told Marijuana Business Daily that the Federal Institute for Drugs and Medical Devices (BfArM) is not allowed to appeal the decision.
Medical cannabis producer Cronos taps major bank for planned CA$100M stock sale
Licensed producer Cronos Group is looking to raise up to 100 million Canadian dollars ($78 million) in what would be only the second equity financing between one of Canada’s biggest banks and a medical marijuana company.
Cronos lists on Nasdaq, as US gets first ‘pure play’ marijuana stock on major exchange
A Canadian marijuana company will become the first “pure play” cannabis listing on a major U.S. stock market, an important milestone for the cannabis industry.
Cronos Group, one of Canada’s largest vertically integrated medical marijuana companies, will start trading Tuesday on the Nasdaq Global Market under the symbol CRON. Cronos will maintain its listing on Toronto’s TSX Venture Exchange.
